Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
A quantitative assessment of primary and secondary immune responses in cattle using the B cell ELISPOT assay Eric A. Lefevre, B. Veronica Carr, Helen Prentice and Bryan Charleston Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berkshire, RG20 7NN, UK Abstract The B cell ELISPOT assay We have developed a method allowing the identification and quantification of Ag-specific plasma cells and memory B cells in the blood of cattle. Using this model, we were able to build a comprehensive picture of the appearance in the blood stream of both these cell types within individual calves immunised with ovalbumin. During the primary response, we detected a burst of ovalbumin-specific plasma cells at days 6 and 7 post-immunisation, which was followed by the production of specific Ab, whereas a gradual increase of memory B cells was only detected from day 15. As expected, a boost immunisation performed 7 weeks later induced a quicker and stronger secondary response. Indeed, a burst of plasma cells was detected in the blood at days 3 and 4, which was followed by a strong increase in Ab titres. Furthermore, a burst of memory B cells, and not a gradual increase, was detected at days 5 and 6 post-boost immunisation. Importantly, we showed a strong correlation between the anti-ovalbumin-specific IgG titres and plasma cell numbers detected in the blood at the peak response after secondary immunisation. This assay allows, in the bovine model, the identification and quantification in the blood of Agspecific plasma cells and memory B cells, using ovalbumin as a model T-dependent Ag (fig 1). As shown below, stimulation of quiescent, memory B cells within PBMC is necessary to induce their differentiation into Ab-secreting cells (ASC) and subsequent detection by the B cell ELISPOT assay. Mixed cellulose ester A. B. Blood sample from calf membranes Histopaque Coating with Ag (ovalbumin) PBMC Plasma cells: No stimulation required ELISPOT assay Memory B cells: Need to be stimulated prior to the ELISPOT assay in order to induce the differentiation of these quiescent B cells into ASC Incubation overnight with mixture of cells Incubation with Sheep anti-bovine IgG-HRP Stimulation for 6 days in complete medium containing PWM+CD40 mAb+IL-2+IL-10 Spot Incubation with chromogen (AEC substrate) ELISPOT assay Figure 1: Protocol and schematic representation of the B cell ELISPOT assay. (A) The B cell ELISPOT assay was performed with freshly isolated and 6 day-stimulated PBMC for the detection of plasma cells and memory B cells, respectively. (B) Schematic procedure of the detection of ASC by ELISPOT. Results Various reagents have been used for inducing the differentiation of human memory B cells, but these are not suitable when using bovine B cells. Here, we show PWM + anti-bovine CD40 mAb+ rhIL-2 + rbIL-10 is a potent differentiation stimulus (fig 2A), which was used in all subsequent experiments aiming at the detection of memory B cells. These activated PBMC were mostly T cell blasts, but numerous plasma cells (positively stained with an anti-bovine light chain mAb) were also detected (fig 2B-D). We determined the kinetics of the appearance of ovalbumin-specific IgG, plasma and memory B cells in the blood following an immunisation and boostimmunisation (fig 3): (i) Primary response: burst of ovalbumin-specific plasma cells detected at days 6 and 7 post-immunisation (pi), followed by the production of specific Ab. Generation of memory B cells detected at a later time-point (starting between days 15 and 21pi and gradually increasing); (ii) Quicker/stronger secondary response: burst of plasma cells detected at days 3 and 4 post-boost immunisation (pb), followed by a strong increase in Ab titres. Burst of memory B cells detected at days 5 and 6 pb. Subsequently, eight calves were immunised with various doses of ovalbumin (results detailed in fig 4A). No correlation was found between the antiovalbumin IgG titres and memory B cell numbers detected at the peak response during the secondary immune response (r value= -0.05, n=8, fig 4B). However, we found a very strong correlation between the anti-ovalbumin IgG titres at day 17pb and plasma cell numbers at day 4pb during the secondary response (r value= 0.95, n=8, fig 4C). A strong correlation (r value= 0.88, n=8) was also observed between the anti-ovalbumin IgG titres determined at a later time point (5 months pb) and the plasma cell numbers detected in the blood at day 4 pb (data not shown). 45% PWM +IL-2 +IL-10 26% PWM +CD40 mAb +IL-2 +IL-10 Counter-staining: May Grunwald Giemsa 107 106 105 100000 4 10 10000 3 10 1000 101002 10101 1001 10000000 1000000 1000000 0 10 20 30 40 50 0 5 10 15 20 25 30 B: Plasma cells D 7% 250 2000 200 1500 150 B 1000 100 50 500 0 0 0 10 20 30 40 50 0 5 10 15 20 25 30 CD8 γδ IHC staining: Anti-Light chain mAb Figure 2: Differentiation of memory B cells into ASC. (A) PBMC isolated from an ova-immunised calf were cultured for 6 days in media alone or in the presence of various combinations of stimuli. The number of ova-specific ASC generated from 106 cultured PBMC (mean of duplicates +/- SD) was determined for each culture condition. (B-D) PBMC isolated from an ova-immunised calf were stimulated for 6 days with PWM, anti-bovine CD40 mAb, rhIL-2 and rbIL-10. The % of CD4+, CD8+ and γδ+ T cells within the resulting population was determined by flow cytometry (B) and cytospin slides from stimulated PBMC were stained with May-Grunwald-Giemsa (arrows indicate cells with plasma cell morphology, C) or by immunohistochemistry for the detection of intracellular Ig (D). Original magnification: x40. Ova: ovalbumin; PWM: Pokeweed mitogen; rhIL-2: recombinant human IL-2; rbIL10: recombinant bovine IL-10; ASC: Ab-secreting cells. 600 20000 15000 400 10000 200 5000 6 CD4 Induced-ASC number C: Memory B cells 0 0 0 10 20 30 40 Days post-immunisation (primary response) 50 0 5 10 15 20 25 30 Days post-boost immunisation (secondary response) Figure 3: Kinetics of Ab titres, plasma and memory B cell numbers after immunisation and boost-immunisation with ovalbumin. Four calves were injected s.c. with 40mg ova per animal in incomplete Freund’s adjuvant (primary response, left panels), then boosted 49 days later with 10mg ova per animal in incomplete Freund’s adjuvant (secondary response, right panels). Blood samples were taken at various time-points following these injections and ova-specific IgG titres (Ab titre, A), plasma cell (B) and memory B cell (C) numbers were determined by ELISA and B cell ELISPOT. Calf number Immunisation regime Primary/Secondary Peak Ab titre (log10) (day 17pb) Peak plasma cell number (day 4pb) Peak memory B cell number (day 6pb) #1 #2 40mg/10mg 40mg/10mg 5.28 ± 0.04 5.86 ± 0.02 70 ± 19 581 ± 44 2,021 ± 0 2,222 ± 226 #3 #4 10mg/10mg 10mg/10mg 5.96 ± 0.01 5.19 ± 0.01 728 ± 79 187 ± 7 382 ± 25 142 ± 14 #5 #6 1mg/10mg 1mg/10mg 5.44 ± 0.05 5.87 ± 0.04 229 ± 3 618 ± 33 352 ± 28 1,553 ± 21 #7 #8 0.1mg/10mg 0.1mg/10mg 6.13 ± 0.02 6.25 ± 0.04 1,601 ± 226 2,879 ± 433 485 ± 23 166 ± 11 C r = -0.05 6.5 6.0 5.5 5.0 2.0 2.5 3.0 3.5 Log 10 ASC (memory B cells) number per 106 PBMC (Day 6pb) Log10 anti-ovalbumin IgG titre (Day 17pb) CD40 mAb +IL-2 +IL-10 ASC number per 106 PBMC Media 107 106 105 100000 4 10 10000 3 10 1000 101002 10101 1001 10000000 Log10 anti-ovalbumin IgG titre (Day 17pb) 200 0 A Ab titres 400 B Mean fluorescence intensity A: C Anti-ovalbumin IgG titre Ova-specific memory B cells 600 6 PBMC pernumber 10 cultured PBMC ASC per 10 ASC number Induced-ASC number 6 cultured 106 PBMC per 10per PBMC A r = 0.95 6.5 6.0 5.5 5.0 1.5 2.0 2.5 3.0 3.5 Log10 ASC (plasma cells) number per 106 PBMC (Day 4pb) Figure 4: Correlation of Log10 anti-ova IgG titres with Log10 plasma cell numbers detected at the peak of the secondary response. (A) Eight calves were injected s.c. with 40, 10, 1 or 0.1mg ova per animal in incomplete Freund’s adjuvant, and then boosted 51 days later with 10mg ova per animal in incomplete Freund’s adjuvant. Blood samples were taken following the boost-injection at the optimal time-points corresponding to the peak response for ova-specific IgG titres (Ab titre, day 17pb), plasma cells (day 4pb) and memory B cells (day 6pb). Plasma cell and memory B cell numbers were expressed as ASC number per 106 PBMC (mean of duplicates +/- SD). (B & C) Pearson’s correlation coefficient (r) was determined to examine the association between the Log10 anti-ova IgG titres and the Log10 memory B cell (B) or plasma cell (C) numbers detected. pb: post-boost immunisation. Conclusion Using the B cell ELISPOT assay, we precisely determined the kinetics of bovine plasma and memory B cells appearing in the blood in response to an immunisation and a boost immunisation with ovalbumin. We also demonstrated a strong correlation between the anti-ovalbumin specific plasma cell numbers at the peak of the secondary response and IgG titres detected subsequently in the blood. The detection and quantification of plasma cells and memory B cells following an immunisation/vaccination strategy could constitute a very effective means to predict, at an early time point, the magnitude and maintenance of the Ab response that will be generated afterwards. Such a method could be valuable for determining the potency of new vaccines and immunisation protocols.